Special Issue "Molecular Imaging as a Tool for Personalized Medicine"
Deadline for manuscript submissions: closed (31 August 2016).
Interests: nuclear-based molecular imaging techniques including PET, SPECT, and PET-MRI; image quantification; immunological-based imaging agents for diagnosis of infection and cancer; radiopharmaceuticals for cancer diagnosis and therapy; radiomics
Special Issues and Collections in MDPI journals
This Special Issue, “Molecular Imaging as a Tool for Personalized Medicine”, will focus on the evolving role of molecular imaging in screening and selecting pharmaceuticals for further development, choosing effective therapies, and monitoring the effects of therapies in the clinic.
Molecular imaging encompasses a wide range of modalities and imaging strategies. Nuclear-based imaging modalities, including positron emission tomography (PET), and magnetic resonance imaging have been joined by ultrasound, optical, and other strategies to interrogate molecular signatures and biochemistry in vivo. Recent advances in chemical synthesis, high throughput screening, and detector capabilities have opened new opportunities to integrate molecular imaging into new arenas of drug discovery and implementation.
This Special Issue will specifically explore the ways in which these new molecular imaging strategies can complement cutting-edge advances in genomics, proteomics, and information analytics, including the explosion of “Big Data” applications, in facilitating the personalization of medicine. Personalized medicine promises to deliver the most effective therapies to patients, guided by a synthesis of information from genomics, proteomics, other clinical data sources, and, now, molecular imaging. Submissions contributing to the understanding of molecular imaging’s role in personalized medicine, through basic science, pre-clinical, and clinical studies are cordially invited.
Both original manuscripts and reviews will be considered.
Dr. Benjamin Franc
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- positron emission tomography
- gamma imaging
- magnetic resonance imaging
- bioluminence/fluorescence imaging
- nanomaterials-based imaging
- immune-based imaging